Related Experiment Video
Updated: Jun 15, 2026

10:28
Probe-based Real-time PCR Approaches for Quantitative Measurement of microRNAs
Published on: April 14, 2015
TaqMan Array Cards in pharmaceutical research
David N Keys1, Janice K Au-Young, Richard A Fekete
1Molecular Biology Division, Life Technologies Corporation, Foster City, CA, USA. david.keys@lifetech.com
Methods in Molecular Biology (Clifton, N.J.)
|March 11, 2010
Summary
TaqMan Array Cards offer accurate, high-throughput gene expression analysis for mRNA and miRNA. This protocol streamlines transcription assays in cultured cells by skipping RNA isolation for faster results.
Area of Science:
- Molecular Biology
- Genomics
- Biotechnology
Background:
- Quantitative analysis of gene expression is crucial in biological research.
- Real-time PCR (Polymerase Chain Reaction) is a standard method for transcript quantification.
- High-throughput methods are needed to analyze multiple genes simultaneously.
Purpose of the Study:
- To describe a protocol for high-throughput transcription analysis using TaqMan Array Cards.
- To optimize the protocol for cultured cells, minimizing hands-on time and pipetting.
- To enable direct cDNA generation from cell lysates, bypassing RNA isolation.
Main Methods:
- Utilizing microfluidic TaqMan Array Cards with 384 reaction chambers.
- Employing Applied Biosystems TaqMan Gene Expression Assays for real-time PCR monitoring.
- Implementing a protocol that skips RNA isolation and generates cDNA directly in lysis solution.
Main Results:
- TaqMan Array Cards provide accurate, sensitive, and simple quantitative analysis of mRNA or miRNA.
- The described protocol minimizes hands-on time and pipetting steps.
- Direct cDNA generation in lysis solution is feasible for transcription assays.
Conclusions:
- TaqMan Array Cards are effective tools for high-throughput gene expression studies.
- The optimized protocol offers an efficient method for analyzing transcription in cultured cells.
- This approach facilitates verification of microarray data and hypothesis-driven gene panel testing.

